Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Dan R. Laks

机构：Voyager Therapeutics (United States) · ORCID：0000-0002-9691-8339

发表论文 78 篇 · 总被引 1484 次 · h-index 18

代表论文

  • SYST-13 AAV VECTOR ENCODING FC MODIFIED HER2 ANTIBODIES REDUCES TUMOR BURDEN WITH MINIMIZED PERIPHERAL EXPOSURE IN MODELS OF BREAST CANCER BRAIN METASTASIS (2023 · Neuro-Oncology Advances)
  • Figure S2 from Pathway-based Approach Reveals Differential Sensitivity to E2F1 Inhibition in Glioblastoma (2023)
  • Figure S1 from Pathway-based Approach Reveals Differential Sensitivity to E2F1 Inhibition in Glioblastoma (2023)
  • Table S1 from Pathway-based Approach Reveals Differential Sensitivity to E2F1 Inhibition in Glioblastoma (2023)
  • Table S3 from Pathway-based Approach Reveals Differential Sensitivity to E2F1 Inhibition in Glioblastoma (2023)
  • Data from Pathway-based Approach Reveals Differential Sensitivity to E2F1 Inhibition in Glioblastoma (2023)